Wilson Sonsini Goodrich & Rosati is a California-headquartered international firm founded in 1961. The firm opened an office in Shanghai in 2007, added one in Hong Kong in 2010, and opened another in Beijing in 2012 with approximately 50 bilingual professions to cater to its clients in the Greater China region.  

Highlights 

The firm is well-known for its expertise in capital markets, securities and venture capital, serving both the Hong Kong and US markets with strong performance in IPOs and de-SPACs. It provides guidance on all kinds of equity transactions in the Greater China area. 

Over the previous year, the firm has been extensively involved in the equity capital markets. This has included notable deals such as providing guidance to the joint sponsors in Black Sesame's HK IPO, being the pioneer in applying for a listing through Chapter 18C under the Listing Rules and successfully passing the hearing, and advising the issuer in Ascentage's US IPO, which was both the first life sciences US IPO of 2025 and the first life sciences company listed on the HKEX  complete a US listing. 

Key clients 

Key clients include Ascentage Pharma Group International, Baiwang, China International Capital Corporation, Huatai Financial Holdings (Hong Kong), and Shenzhen Dobot Corp.